Free provider profile
BRETT FRANS, APRN
PENSACOLA, FL
Find similar providers: Nurse Practitioner, Family in PENSACOLA, FL
Practice contact details
Source: CMS NPPES · published practice information
Practice phone
850-476-3131
Fax
850-476-4848
Practice address
4300 BAYOU BLVD STE 17D, PENSACOLA, FL, 32503
- Registry updated
- 2024-05-07
- NPI issued
- 2019-03-29
- RepVector retrieved
- 11/21/2026
A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.
Specialties & registration
CMS NPPES taxonomy classifications · not verification of certification or services offered
Nurse Practitioner, Family
363LF0000X
Primary
1 registered practice location · A registry listing does not establish active practice, referral relationships or insurance participation.
Need more providers like BRETT FRANS?
See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.
Rep intel
What BRETT FRANS prescribes and who else does
Top Medicare Part D drugs by claims (public CMS data):
- Biktarvy
- Dovato
- Tivicay
- Descovy
- Symtuza
Your next referral list starts here
Provider + market indicator
A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.
Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
6,109
Medicare patients
210
Part D drug cost
$5,695,208
Brand-name share
Not published
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Biktarvy (Bictegrav/Emtricit/Tenofov Ala) | 527 | $2,042,299 |
| Dovato (Dolutegravir Sodium/Lamivudine) | 221 | $638,474 |
| Symtuza (Darunavir/Cob/Emtri/Tenof Alaf) | 137 | $628,528 |
| Tivicay (Dolutegravir Sodium) | 189 | $460,777 |
| Descovy (Emtricitabine/Tenofov Alafenam) | 159 | $376,621 |
| Triumeq (Abacavir/Dolutegravir/Lamivudi) | 69 | $254,446 |
| Genvoya (Elviteg/Cob/Emtri/Tenof Alafen) | 44 | $176,350 |
| Odefsey (Emtricitab/Rilpiviri/Tenof Ala) | 37 | $134,526 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Latest Medicare Part B billing
CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.
Loading the latest published CMS billing file…
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
Checking Open Payments…
Industry payments across FL — which companies pay providers there.
Open Payments page for this provider
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.
